Circulating miRNA could be a potential biomarker for early diagnosis of MMNovember 24, 2020Multiple MyelomaOncologyHematologic Malignancies
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemiaNovember 24, 2020Mixed TopicsHematologic Malignancies
Immunotherapy for ALL: Roles emerge in R/R disease, MRD+ diseaseNovember 17, 2020Hematologic Malignancies
VTEs tied to immune checkpoint inhibitor cancer treatmentNovember 17, 2020PulmonologyCardiologyMixed TopicsOncologyHematologic Malignancies
Using telehealth to deliver palliative care to cancer patients November 17, 2020Breast CancerGenitourinary CancerLung CancerRare DiseasesOncologyHematologic Malignancies
Home care for bortezomib safe and reduces hospital visits in myeloma patientsNovember 11, 2020Multiple MyelomaHematologic Malignancies
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patientsNovember 10, 2020Hematologic Malignancies
Beat AML: Precision medicine strategy feasible, superior to SOC for AMLNovember 10, 2020AMLHematologic Malignancies
Novel treatments under study for chronic graft-versus-host disease in allo-HCTOctober 27, 2020Hematologic Malignancies
Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLLOctober 23, 2020Hematologic Malignancies
Socioeconomic factors affect survival of multiple myeloma patientsOctober 22, 2020Multiple MyelomaOncologyHematologic Malignancies
Are oncologists ready to confront a second wave of COVID-19?October 21, 2020Breast CancerCOVID-19 UpdatesGenitourinary CancerLung CancerMelanomaHematologic Malignancies
